Skip to main content

Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.

Publication ,  Journal Article
Harskamp, RE; Lopes, RD; Baisden, CE; de Winter, RJ; Alexander, JH
Published in: Ann Surg
May 2013

OBJECTIVE: To review our current understanding of the epidemiology and pathogenesis of vein graft failure (VGF), give an overview of current preventive and interventional measures, and explore strategies that may improve vein graft patency. BACKGROUND: VGF and progression of native coronary artery disease limit the long-term efficacy of coronary artery bypass graft surgery. METHODS: We reviewed the published literature on the pathophysiology, prevention, and/or treatment of VGF by searching the MEDLINE (January 1, 1966-January 1, 2012), EMBASE (January 1, 1980-January 1, 2012), and Cochrane (January 1, 1995-January 1, 2012) databases. In addition, we reviewed references from the selected articles for studies not identified in the initial search. Basic science and clinical studies were included; non-English language publications were excluded. RESULTS: Acute thrombosis, neointimal hyperplasia, and accelerated atherosclerosis are the 3 mechanisms that lead to VGF. Preventive measures include matching and quality assessment of conduit and target vessel, lipid-lowering drugs, antithrombotic therapy, and cessation of smoking. Treatment of VGF includes medical therapy, percutaneous intervention, and redo coronary artery bypass graft surgery. In patients undergoing graft intervention, the use of drug-eluting stents, antiplatelet agents, and embolic protection devices may improve clinical outcomes. CONCLUSIONS: Despite advances in management, VGF remains one of the leading causes of poor in-hospital and long-term outcomes after coronary artery bypass graft surgery. New developments in VGF prevention such as gene therapy, external graft support, fully tissue-engineered grafts, hybrid grafts, and synthetic conduits are promising but unproven. Future efforts to reduce VGF require a multidisciplinary approach with a primary focus on prevention.

Duke Scholars

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

May 2013

Volume

257

Issue

5

Start / End Page

824 / 833

Location

United States

Related Subject Headings

  • Treatment Failure
  • Surgery
  • Stents
  • Saphenous Vein
  • Risk Reduction Behavior
  • Risk Factors
  • Reoperation
  • Percutaneous Coronary Intervention
  • Humans
  • Graft Occlusion, Vascular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harskamp, R. E., Lopes, R. D., Baisden, C. E., de Winter, R. J., & Alexander, J. H. (2013). Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg, 257(5), 824–833. https://doi.org/10.1097/SLA.0b013e318288c38d
Harskamp, Ralf E., Renato D. Lopes, Clinton E. Baisden, Robbert J. de Winter, and John H. Alexander. “Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.Ann Surg 257, no. 5 (May 2013): 824–33. https://doi.org/10.1097/SLA.0b013e318288c38d.
Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013 May;257(5):824–33.
Harskamp, Ralf E., et al. “Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.Ann Surg, vol. 257, no. 5, May 2013, pp. 824–33. Pubmed, doi:10.1097/SLA.0b013e318288c38d.
Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013 May;257(5):824–833.

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

May 2013

Volume

257

Issue

5

Start / End Page

824 / 833

Location

United States

Related Subject Headings

  • Treatment Failure
  • Surgery
  • Stents
  • Saphenous Vein
  • Risk Reduction Behavior
  • Risk Factors
  • Reoperation
  • Percutaneous Coronary Intervention
  • Humans
  • Graft Occlusion, Vascular